SLU-PP-332 is a synthetic small molecule studied as an estrogen-related receptor agonist in cellular energy metabolism and mouse exercise and obesity models.
Explore the research profileSubmit an unpaid laboratory order request for manual review. Availability and any pending amounts require confirmation.
Catalog quantities are not assay results.
Small-molecule estrogen-related receptor agonist
SLU-PP-332 is a chemical tool targeting the estrogen-related receptors ERRα, ERRβ and ERRγ. Despite their names, these nuclear receptors are distinct from the classical estrogen receptors. SLU-PP-332 is a small molecule rather than a peptide or a naturally occurring exercise hormone.
This reference describes the published literature. Exact supplied form and chemical specifications require product-specific documentation. The studies are linked in Selected literature.
ERRs regulate gene programs associated with energy metabolism. Discovery experiments found activity across all three subtypes, with greatest potency at ERRα in the reported system. The compound changed mitochondrial and respiratory measurements in a muscle cell line and activated an exercise-associated transcriptional program in mice.
The discovery study examined receptor activation and mitochondrial function in cultured skeletal-muscle cells. Such assays test a molecular hypothesis under controlled conditions. Increased cellular respiration alone does not demonstrate improved health or performance in a whole organism. [1]
In mice, investigators reported changes in oxidative muscle-fiber characteristics and exercise endurance. ERRα activity was important for the measured response. Calling the compound an exercise mimetic describes selected experimental effects, not replacement of the many physiological consequences of physical activity. [1]
A follow-up study examined diet-induced obese and genetically obese mice. Reported outcomes included increased energy expenditure and fat oxidation, reduced fat accumulation and improved insulin sensitivity. These are model-specific animal findings rather than human weight-management data. [2]
Study topics describe the cited models, not established benefits of this catalog material.
The cited primary publications provide mechanistic and organism-level preclinical findings. Neither is a human intervention trial. They establish a research rationale for studying ERR activation while leaving the translation from laboratory models to human physiology unresolved.
Species differences, exposure, off-target effects and prolonged receptor activation require separate investigation. An endurance result in mice does not establish cardiovascular benefit, safety or human athletic effects. Findings should not be transferred to other ERR agonists, and the literature does not validate WYZ material identity or equivalence.
Primary studies and clearly identified supporting sources. Each link opens the original record.
Discovery pharmacology, muscle-cell assays and mouse endurance experiments.
Obesity-model metabolic outcomes; journal publication year is 2024.
Literature reviewed October 2026. This is a selected research overview, not an exhaustive systematic review. Published findings do not establish the identity, purity, sterility or suitability of any WYZ batch. For laboratory research only; not for human or veterinary use.
Final product specifications and product-specific storage instructions have not been supplied. Review the original documentation and your laboratory’s procedures before obtaining or using the material.
For qualified laboratory researchers. Not for human or veterinary use. Product information is not medical advice or a recommendation for personal use.
What to look for in a COAOther single compounds in the collection.
Metabolic Research
Retatrutide is a synthetic peptide studied for coordinated activation of three metabolic hormone receptors, with human research examining glucose regulation, appetite, body weight and liver fat.
Metabolic Research
MOTS-c is a mitochondrial-derived peptide studied in metabolic signaling and skeletal-muscle adaptation, with experimental interventions supported mainly by cell and animal evidence.
Dermal Research
GHK-Cu is a copper complex of glycyl-histidyl-lysine studied for its effects on extracellular-matrix production and remodeling in experimental tissue-repair systems.
